BAXTER Trademark

Trademark Overview


On Thursday, February 22, 2024, a trademark application was filed for BAXTER with the United States Patent and Trademark Office. The USPTO has given the BAXTER trademark a serial number of 98416599. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 21, 2024. This trademark is owned by Baxter International Inc.. The BAXTER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, injection solutions for human use in the treatment of cardiovascular disease; preparations for human health care in the treatment of cardiovascular disease; cardiovascular pharmaceutical preparations; local anesthetics for human use; inhalant anesthetic; pharmaceutical preparations for the induction of local anesthesia; general anesthetics for human use; transdermal patches featuring scopolamine for treatment of nausea and vomiting; antibiotics for human use; sedatives for human use; injectable pharmaceuticals for treatment of infections, bacterial infections, viral infections, pain, fever, hypertension, low blood pressure, heart disease, chest pain, hemodynamic imbalances, blood clots, ulcers, ventricular fibrillation, yeast infections, fungal infections, heart failure, diabetes, cancer, nausea and vomiting, edema, constipation, cirrhosis, opioid overdose, poisoning, heavy bleeding, dehydration, swelling, low magnesium, acne, rapid heartbeats, and low ...
baxter

General Information


Serial Number98416599
Word MarkBAXTER
Filing DateThursday, February 22, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Goods and ServicesPharmaceutical products, namely, injection solutions for human use in the treatment of cardiovascular disease; preparations for human health care in the treatment of cardiovascular disease; cardiovascular pharmaceutical preparations; local anesthetics for human use; inhalant anesthetic; pharmaceutical preparations for the induction of local anesthesia; general anesthetics for human use; transdermal patches featuring scopolamine for treatment of nausea and vomiting; antibiotics for human use; sedatives for human use; injectable pharmaceuticals for treatment of infections, bacterial infections, viral infections, pain, fever, hypertension, low blood pressure, heart disease, chest pain, hemodynamic imbalances, blood clots, ulcers, ventricular fibrillation, yeast infections, fungal infections, heart failure, diabetes, cancer, nausea and vomiting, edema, constipation, cirrhosis, opioid overdose, poisoning, heavy bleeding, dehydration, swelling, low magnesium, acne, rapid heartbeats, and low calcium; prescription medicines, namely, pills, tablets, capsules and pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention of nausea, vomiting, and damage to bladder; pharmaceutical preparations to temporarily arrest the heart; pharmaceutical preparations for use in cardiac rhythm support; potassium preparations for pharmaceutical purposes; insulin; pharmaceutical preparations, namely, irrigation solutions for flushing, rinsing and cleansing of body tissues, body cavities, and wounds; medical instruments, namely, medical containers and medical bags sold filled with medical liquids and solutions, namely, irrigation solutions for cleansing wounds; amino acid preparations for medical purposes; liquid nutritional supplement; liquid vitamin supplements; saline solution for medical purposes; sterile water for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code005
First Use Anywhere DateSunday, January 1, 2023
First Use In Commerce DateSunday, January 1, 2023

Trademark Owner History


Party NameBaxter International Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Party NameBaxter International Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events


Event DateEvent Description
Monday, February 26, 2024NEW APPLICATION ENTERED
Monday, February 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2024ASSIGNED TO EXAMINER
Friday, April 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 11, 2024NON-FINAL ACTION WRITTEN
Thursday, April 11, 2024NON-FINAL ACTION E-MAILED
Thursday, April 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED